Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.
An international coalition made the lofty promise at last year’s World Hepatitis Summit, but few are delivering, according to WHO.
Highlights from the hep C–related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle
Widespread treatment of hep C among this population would likely drive down transmission rates. But cost is a major barrier.
With eradication of hepatitis C at least theoretically feasible, researchers examine the roadblocks to accomplishing such a mammoth task.
With numerous obstacles preventing widespread treatment of the U.S. hepatitis C population, how can the health care system successfully...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.